These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 933994)

  • 21. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HBs-antigenemia in patients with pulmonary tuberculosis (author's transl)].
    Fill WD; Neumann M
    Wien Med Wochenschr; 1980 Jun; 130(12):399-41. PubMed ID: 7424025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis-B-antigen in cases of viral hepatitis in Munich (author's transl)].
    Liebermeister RG
    Med Klin; 1974 Jul; 69(27):1202-7. PubMed ID: 4368147
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the quantitative, morphological and functional changes of the thrombocytes in chronic liver diseases].
    KORINTH E
    Acta Hepatosplenol; 1962 Apr; 9():65-73. PubMed ID: 14458420
    [No Abstract]   [Full Text] [Related]  

  • 26. [Expression of hepatitis B virus antigen in brain tissue from liver cirrhosis patients with hepatitis B and its significance].
    Shang Q; Zhang G; Xu C; Chen CX; Yu JG; Yan CY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):277-9. PubMed ID: 11986706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of Australia-antigen detection (author's transl)].
    Weise W; Schlicht L; Martin W
    Med Klin; 1975 Oct; 70(40):1598-1601. PubMed ID: 1186571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].
    Aprosina ZG; Lopatkina TN; Iakovenko EP; Krel' PE; Saiapina ES
    Ter Arkh; 1988; 60(11):23-8. PubMed ID: 3238571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pseudothrombocytopenia and the experimental evaluation for platelet counting (author's transl)].
    Yamamoto K; Watada M; Mishina Y
    Rinsho Byori; 1977 Jan; 25(1):67-72. PubMed ID: 557633
    [No Abstract]   [Full Text] [Related]  

  • 31. [Quantitative immunoelectrophoresis as a method for determination of hepatitis B antigen. Standardization and comparison with other methods (author's transl)].
    Yano M; Tripatzis I
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):174-86. PubMed ID: 4143165
    [No Abstract]   [Full Text] [Related]  

  • 32. [Data on hepatitis antigen (HAA)].
    Renger F; Reimann W; Frank J; Kobe E; Vogel C; Vogel H; Kayser W; Bosse W; Geyer F
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):83-6. PubMed ID: 4347640
    [No Abstract]   [Full Text] [Related]  

  • 33. [Australia-antigen in patients with acute and chronic liver diseases].
    Nielsen PE; Nielsen JO; Dietrichson O
    Ugeskr Laeger; 1970 May; 132(19):875-9. PubMed ID: 5447319
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
    Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
    Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The serum prealbumin significance in differential diagnosis of the liver diseases (author's transl)].
    Gróza S
    Med Klin; 1976 Feb; 71(9):378-9. PubMed ID: 1256337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HB antigen and liver diseases-pathological and immunopathological study (author's transl)].
    Shikata T
    Rinsho Byori; 1975 Jun; 23(6):406-11. PubMed ID: 1236999
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of ketamine in patients with liver damage (author's transl)].
    Schaps D; Hauenschild E
    Anaesthesist; 1977 Apr; 26(4):172-5. PubMed ID: 860823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An epidemiological study about viral hepatitis in the region of Hannover (Lower Saxonia). I. Results 1972-73 (author's transl)].
    Wehrmann M; Müller R; Kramer R; Willers H; Knocke KW; Deicher H; Höpken W
    Med Klin; 1974 Feb; 69(8):325-32. PubMed ID: 4826681
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.